Our study thus eludicated the overall effect of targeting NRP2 in both cancer cells and osteoclasts in PCa bone metastasis, which can prove to be beneficial in the development of an effective treatment strategy. This evidence concerns the gene NRP2 and posterior cortical atrophy.